Avior Wealth Management, LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Avior Wealth Management, LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$2,930
+2.4%
1,0000.0%0.00%
Q2 2023$2,860
-7.4%
1,0000.0%0.00%
Q1 2023$3,090
+46.4%
1,0000.0%0.00%
Q4 2022$2,110
-29.7%
1,0000.0%0.00%
Q3 2022$3,0000.0%1,0000.0%0.00%
Q2 2022$3,000
-57.1%
1,0000.0%0.00%
-100.0%
Q1 2022$7,0000.0%1,0000.0%0.00%0.0%
Q4 2021$7,000
-36.4%
1,0000.0%0.00%0.0%
Q3 2021$11,0001,0000.00%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders